T Rowe Price Etf Profile
| TMED Etf | USD 26.68 0.59 2.26% |
PerformanceMild
| Odds Of DistressLow
|
T Rowe is trading at 26.68 as of the 30th of September 2025, a 2.26 percent increase since the beginning of the trading day. The etf's lowest day price was 26.27. T Rowe has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat mild performance during the last 90 days. The performance scores are derived for the period starting the 2nd of July 2025 and ending today, the 30th of September 2025. Click here to learn more.
Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California. Trimedyne operates under Medical Devices classification in USA and is traded on BATS Exchange.. The company has 122.64 K outstanding shares of which 389 shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. More on T Rowe Price
Moving together with TMED Etf
TMED Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Health Care ETFs, Sector ETFs, Health, Medical Devices, Healthcare (View all Sectors) |
| Issuer | T. Rowe Price |
| Inception Date | 2025-06-12 |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 12.94 Million |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Blended Development |
| Region | Global |
| Administrator | State Street Bank and Trust Company |
| Advisor | T. Rowe Price Associates, Inc. |
| Custodian | State Street Bank and Trust Company |
| Distributor | T. Rowe Price Investment Services, Inc. |
| Portfolio Manager | Sal Rais, Jon Davis Wood |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 31-Dec |
| Exchange | NASDAQ |
| Number of Constituents | 104 |
| Market Maker | Citadel |
| Total Expense | 0.44 |
| Management Fee | 0.44 |
| Country Name | USA |
| Code | TMED |
| Updated At | 28th of September 2025 |
| Name | T. Rowe Price Health Care ETF |
| Currency Name | US Dollar |
| Currency Code | USD |
| Open Figi | BBG01VCLD7N5 |
| Type | ETF |
T Rowe Price [TMED] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Health Care ETFs. T Rowe Price at this time have in assets.
T Rowe Price currently holds about 1.05 M in cash with (264 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.54.
Check T Rowe Probability Of Bankruptcy
Geographic Allocation (%)
T Rowe Price Currency Exposure
T Rowe Price holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of T Rowe will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in T Rowe Price.
Top T Rowe Price Etf Constituents
| AVTR | Avantor | Stock | Health Care | |
| ETNB | 89bio Inc | Stock | Health Care | |
| GILD | Gilead Sciences | Stock | Health Care | |
| MTSR | Metsera, Common Stock | Stock | Health Care | |
| ALGN | Align Technology | Stock | Health Care | |
| NVCR | Novocure | Stock | Health Care | |
| MTD | Mettler Toledo International | Stock | Health Care | |
| MCK | McKesson | Stock | Health Care |
T Rowe Price Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in T Rowe. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | 0.0566 | |||
| Jensen Alpha | 0.0823 | |||
| Total Risk Alpha | (0.06) | |||
| Sortino Ratio | 0.0049 |
T Rowe Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T Rowe Price. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in commodities. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
The market value of T Rowe Price is measured differently than its book value, which is the value of TMED that is recorded on the company's balance sheet. Investors also form their own opinion of T Rowe's value that differs from its market value or its book value, called intrinsic value, which is T Rowe's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T Rowe's market value can be influenced by many factors that don't directly affect T Rowe's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T Rowe's value and its price as these two are different measures arrived at by different means. Investors typically determine if T Rowe is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T Rowe's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.